ERBB2 and breast carcinoma: In a previous study, it has been demonstrated that HER2 overexpression triggers activation of the HSF1-HSP90 axis and subsequently leads to the stabilization of HSP90 client proteins such as AKT, mTOR and HSF1 itself, thereby promoting tumor growth in HER2-positive breast cancer 33.